| Dr Elaine M Brenner, MD | |
|
2300 Haggerty Rd, 2150, West Bloomfield, MI 48323-2184 | |
| (248) 926-6610 | |
| (248) 926-6611 |
| Full Name | Dr Elaine M Brenner |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 36 Years |
| Location | 2300 Haggerty Rd, West Bloomfield, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255391397 | NPI | - | NPPES |
| P00055649 | Other | MI | RAILROAD MEDICARE |
| 0F37550 | Other | MI | BCBSM |
| 383468933 | Other | MI | COMMERCIAL INSURANCE CO. |
| F01718 | Other | MI | HAP |
| 0F37550 | Other | MI | BCN |
| 104530972 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 4301053483 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Mercy Home Care, Ann Arbor | Farmington hills, MI | Home health agency |
| St Joseph Mercy Oakland | Pontiac, MI | Hospital |
| Huron Valley-sinai Hospital | Commerce township, MI | Hospital |
| Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
| Ascension Providence Hospital, Southfield And Novi | Southfield, MI | Hospital |
| Henry Ford West Bloomfield Hospital | West bloomfield, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Michigan Healthcare Professionals Pc | 0345413258 | 448 |
News Archive
Boehringer Ingelheim has today announced that it has updated the US prescribing information for Pradaxa (dabigatran etexilate) in alignment with the US Food and Drug Administration (FDA) to affirm that "Pradaxa 150mg twice daily was superior in reducing ischemic and hemorrhagic strokes relative to warfarin."
By allowing states the flexibility to make key decisions, the administration avoided a "political hot potato" regarding essential benefits -; the medical benefits insurers must cover under the U.S. health care.
A rare, small RNA turns a gene-splicing machine into a switch that controls the expression of hundreds of human genes. Howard Hughes Medical Institute Investigator and professor of Biochemistry Gideon Dreyfuss, PhD, and his team from the Perelman School of Medicine at the University of Pennsylvania, discovered an entirely new aspect of the gene-splicing process that produces messenger RNA (mRNA).
The results of a new survey have revealed that one in four New Yorkers have elevated levels of mercury in their blood which are higher than others both locally and nationally.
ApoPharma Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10 - 2 to recommend that the FDA grant accelerated approval of Ferriprox (deferiprone), an oral iron chelator, for the treatment of patients with transfusional iron overload when current chelation therapy is inadequate.
› Verified 1 days ago
| Entity Name | Michigan Healthcare Professionals Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295023547 PECOS PAC ID: 0345413258 Enrollment ID: O20111109000027 |
News Archive
Boehringer Ingelheim has today announced that it has updated the US prescribing information for Pradaxa (dabigatran etexilate) in alignment with the US Food and Drug Administration (FDA) to affirm that "Pradaxa 150mg twice daily was superior in reducing ischemic and hemorrhagic strokes relative to warfarin."
By allowing states the flexibility to make key decisions, the administration avoided a "political hot potato" regarding essential benefits -; the medical benefits insurers must cover under the U.S. health care.
A rare, small RNA turns a gene-splicing machine into a switch that controls the expression of hundreds of human genes. Howard Hughes Medical Institute Investigator and professor of Biochemistry Gideon Dreyfuss, PhD, and his team from the Perelman School of Medicine at the University of Pennsylvania, discovered an entirely new aspect of the gene-splicing process that produces messenger RNA (mRNA).
The results of a new survey have revealed that one in four New Yorkers have elevated levels of mercury in their blood which are higher than others both locally and nationally.
ApoPharma Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10 - 2 to recommend that the FDA grant accelerated approval of Ferriprox (deferiprone), an oral iron chelator, for the treatment of patients with transfusional iron overload when current chelation therapy is inadequate.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elaine M Brenner, MD 2300 Haggerty Rd, 2150, West Bloomfield, MI 48323-2184 Ph: (248) 926-6610 | Dr Elaine M Brenner, MD 2300 Haggerty Rd, 2150, West Bloomfield, MI 48323-2184 Ph: (248) 926-6610 |
News Archive
Boehringer Ingelheim has today announced that it has updated the US prescribing information for Pradaxa (dabigatran etexilate) in alignment with the US Food and Drug Administration (FDA) to affirm that "Pradaxa 150mg twice daily was superior in reducing ischemic and hemorrhagic strokes relative to warfarin."
By allowing states the flexibility to make key decisions, the administration avoided a "political hot potato" regarding essential benefits -; the medical benefits insurers must cover under the U.S. health care.
A rare, small RNA turns a gene-splicing machine into a switch that controls the expression of hundreds of human genes. Howard Hughes Medical Institute Investigator and professor of Biochemistry Gideon Dreyfuss, PhD, and his team from the Perelman School of Medicine at the University of Pennsylvania, discovered an entirely new aspect of the gene-splicing process that produces messenger RNA (mRNA).
The results of a new survey have revealed that one in four New Yorkers have elevated levels of mercury in their blood which are higher than others both locally and nationally.
ApoPharma Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10 - 2 to recommend that the FDA grant accelerated approval of Ferriprox (deferiprone), an oral iron chelator, for the treatment of patients with transfusional iron overload when current chelation therapy is inadequate.
› Verified 1 days ago
Dr. Mark D Wolf, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2055 Bloomfield Woods Ct, West Bloomfield, MI 48323 Phone: 248-454-0888 Fax: 248-332-0451 | |
Jeffrey M. Finn, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 6777 West Maple Road, West Bloomfield, MI 48323 Phone: 248-661-6450 Fax: 248-661-6649 | |
Dr. Elizabeth Bulat, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6773 W Maple Rd, West Bloomfield, MI 48322 Phone: 248-788-3013 | |
Michael Garcia, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6900 Orchard Lake Rd, Suite 204, West Bloomfield, MI 48322 Phone: 248-855-5620 Fax: 248-855-5628 | |
Maribeth Knight, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5777 W Maple Rd Ste 140, West Bloomfield, MI 48322 Phone: 248-406-1000 Fax: 248-406-1001 | |
Dr. Dana Chevelle Yuzon, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2300 Haggerty Rd, Suite 2150, West Bloomfield, MI 48323 Phone: 248-926-6610 Fax: 248-926-6611 | |
Lisa B. Elconin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5777 W Maple Rd, Suite 140, West Bloomfield, MI 48322 Phone: 248-406-1000 Fax: 248-406-1001 |